PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Disease Reportskidney diseases
MeSH D007674 - kidney diseases
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
See list view
D014570:Urologic diseases
0 Companies
0 Drugs
Success rate
D007674: 
Kidney diseases
12 Companies
1 Drug
$
Success rate
D001002:Anuria
13 Companies
2 Drugs
$
Success rate
D003919:Diabetes insipidus
0 Companies
0 Drugs
Success rate
D003928:Diabetic nephropathies
86 Companies
28 Drugs
$
Success rate
D006530:Hepatorenal syndrome
0 Companies
0 Drugs
Success rate
D006869:Hydronephrosis
0 Companies
0 Drugs
Success rate
D006959:Hyperoxaluria
0 Companies
0 Drugs
Success rate
D006977:Renal hypertension
0 Companies
0 Drugs
Success rate
D007673:Kidney cortex necrosis
0 Companies
0 Drugs
Success rate
D007680:Kidney neoplasms
18 Companies
5 Drugs
$
Success rate
D007681:Kidney papillary necrosis
0 Companies
0 Drugs
Success rate
D009393:Nephritis
0 Companies
0 Drugs
Success rate
D009397:Nephrocalcinosis
0 Companies
0 Drugs
Success rate
D009400:Nephrosclerosis
0 Companies
0 Drugs
Success rate
D009401:Nephrosis
0 Companies
0 Drugs
Success rate
D010501:Perinephritis
0 Companies
0 Drugs
Success rate
D012078:Renal artery obstruction
0 Companies
0 Drugs
Success rate
D012080:Chronic kidney disease-mineral and bone disorder
0 Companies
0 Drugs
Success rate
D014398:Renal tuberculosis
0 Companies
0 Drugs
Success rate
D014511:Uremia
0 Companies
0 Drugs
Success rate
D015211:Zellweger syndrome
2 Companies
1 Drug
$
Success rate
D015499:Inborn errors renal tubular transport
0 Companies
0 Drugs
Success rate
D016263:Aids-associated nephropathy
0 Companies
0 Drugs
Success rate
D051437:Renal insufficiency
0 Companies
0 Drugs
Success rate
D052177:Cystic kidney diseases
0 Companies
0 Drugs
Success rate
D053040:Nephrolithiasis
0 Companies
0 Drugs
Success rate
D059228:Renal nutcracker syndrome
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
No Data
Clinical Trials
Historical Success Rate
Phase 1
67%
32/48
Phase 2
37%
21/57
Phase 3
41%
16/39
Approved: 1Overall Success rate: 10%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Teva
Dopamine
Abbott Biotherapeutics
Dopamine
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use